SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-21-143057
Filing Date
2021-11-23
Accepted
2021-11-23 16:31:51
Documents
12
Period of Report
2021-08-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2133571d2_8ka.htm   iXBRL 8-K/A 23627
  Complete submission text file 0001104659-21-143057.txt   193639

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA twst-20210805.xsd EX-101.SCH 3046
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE twst-20210805_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE twst-20210805_pre.xml EX-101.PRE 22373
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2133571d2_8ka_htm.xml XML 3479
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Filer) CIK: 0001581280 (see all company filings)

IRS No.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K/A | Act: 34 | File No.: 001-38720 | Film No.: 211438933
SIC: 2836 Biological Products, (No Diagnostic Substances)